Clinical Trials Enrollment Dashboard

Track patients currently enrolled in active clinical trials

Active Clinical Trials

3 trials with active patient enrollment • Showing all patients

Phase 2b5 enrolled
Extended-Release Naltrexone Plus Brief Cognitive Behavioral Intervention for Stress-Triggered Hazardous Drinking
Protocol: CT-2025-AUD-012
Sponsor: Harbor Neuroscience & Behavioral Health
Area: Addiction / Psychiatry
Phase 36 enrolled
Oral Factor XIa Inhibitor (FXIaX) Versus Standard Direct Oral Anticoagulant Therapy for Acute Symptomatic Pulmonary Embolism
Protocol: CT-2025-VTE-007
Sponsor: ThromboX Biotech
Area: Cardiology / Thrombosis
Assessment1 enrolled
Acute Positional Vertigo Evaluation and Management
Protocol: AC-2025-NEURO-002
Sponsor: Primary Care Clinic — Neurology Screening
Area: Neurology / Vestibular Disorders
Enrolled Patients

12 patients across all trials